Becton, Dickinson and Company (BDXA) Stock Analysis
DELISTED
What happened to Becton, Dickinson and Company (BDXA) stock?
Becton, Dickinson and Company (BDXA) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
P/E 211.57 means the share price is 211.57 times one year of earnings per share. Market cap $55.9B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Becton, Dickinson and Company (BDXA). Becton, Dickinson and Company (BDXA) is a global medical technology company that develops, manufactures, and sells a broad range of medical supplies, devices, laboratory equipment, and diagnostic products.
Last analyzed: Mar 18, 2026Becton, Dickinson and Company (BDXA) Healthcare & Pipeline Overview
More about this archive record
Can I still buy BDXA shares?
No. BDXA stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for BDXA elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before BDXA stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Becton, Dickinson and Company. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.